{
    "startDate": "2021-04-01",
    "endDate": "2021-12-31",
    "year": "2022",
    "quarter": "Q3",
    "symbol": "MYOV",
    "data": {
        "bs": [
            {
                "label": "Operating lease right-of-use asset",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 8405000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -17285000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 6737000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 6737000
            },
            {
                "label": "Amounts due to related parties",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 391000
            },
            {
                "label": "Deferred revenue, non-current",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 400849000
            },
            {
                "label": "Long-term debt, less current maturities (related party)",
                "concept": "DueToRelatedPartiesNoncurrent",
                "unit": "usd",
                "value": 358700000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -1192844000
            },
            {
                "label": "Amount due from related party",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 550000
            },
            {
                "label": "Commitments and contingencies (Note 9)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 70020000
            },
            {
                "label": "Total liabilities and shareholders\u2019 deficit",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 604292000
            },
            {
                "label": "Share-based compensation liabilities",
                "concept": "DeferredCompensationShareBasedArrangementsLiabilityCurrent",
                "unit": "usd",
                "value": 2724000
            },
            {
                "label": "Share-based compensation liabilities",
                "concept": "DeferredCompensationShareBasedArrangementsLiabilityCurrent",
                "unit": "usd",
                "value": 2700000.0
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "myov:AccruedAndOtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 58423000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "myov:AccruedAndOtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 58423000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 777844000
            },
            {
                "label": "Cost share advance from Pfizer",
                "concept": "myov:CollaborativeArrangementLiabilityCurrent",
                "unit": "usd",
                "value": 55026000
            },
            {
                "label": "Cost share advance from Pfizer",
                "concept": "myov:CollaborativeArrangementLiabilityCurrent",
                "unit": "usd",
                "value": 55000000.0
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 18910000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 100564000
            },
            {
                "label": "Long-term operating lease liability",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 7618000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 2952000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 18181000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 371000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 574754000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 12130000
            },
            {
                "label": "Amounts due to Pfizer",
                "concept": "myov:AccruedLiabilitiesCollaborationAgreementCurrent",
                "unit": "usd",
                "value": 37727000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 457742000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 457742000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 604292000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 269037000
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 2052000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 20795000
            },
            {
                "label": "Cost share advance from Pfizer, non-current",
                "concept": "myov:CollaborativeArrangementLiabilityNoncurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 1036575000
            },
            {
                "label": "Total shareholders\u2019 deficit",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -432283000
            },
            {
                "label": "Total shareholders\u2019 deficit",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -432283000
            },
            {
                "label": "Common shares, $0.000017727 par value, 564,111,242 shares authorized; 93,658,206 and 91,000,869 issued and outstanding at December\u00a031, 2021 and March\u00a031, 2021, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 2000
            }
        ],
        "cf": [
            {
                "label": "Maturities of marketable securities",
                "concept": "myov:ProceedsFromMaturitiesPrepaymentsAndCallsOfMarketableSecurities",
                "unit": "usd",
                "value": 59252000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
                "unit": "usd",
                "value": 13811000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 4126000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 7259000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 15340000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayableTrade",
                "unit": "usd",
                "value": -5679000
            },
            {
                "label": "Amounts due to Pfizer",
                "concept": "myov:IncreaseDecreaseInAccruedLiabilitiesCollaborationAgreementCurrent",
                "unit": "usd",
                "value": 35773000
            },
            {
                "label": "Reclassification of share-based compensation liabilities to additional paid-in capital upon settlement of awards",
                "concept": "myov:NoncashReclassificationOfShareBasedCompensationExpenseFromLiabilitiesToAdditionalPaidInCapital",
                "unit": "usd",
                "value": 20650000
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -9000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 3641000
            },
            {
                "label": "Operating lease liabilities",
                "concept": "IncreaseDecreaseInOperatingLeaseLiability",
                "unit": "usd",
                "value": -1326000
            },
            {
                "label": "Capital contribution- other",
                "concept": "myov:ProceedsFromCapitalContributionOther",
                "unit": "usd",
                "value": 1280000
            },
            {
                "label": "Net cash (used in) provided by operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -168472000
            },
            {
                "label": "Amortization of operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAssetAmortizationExpense",
                "unit": "usd",
                "value": 1250000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 19142000
            },
            {
                "label": "Change in fair value of share-based awards recorded to additional paid-in capital",
                "concept": "myov:NoncashIncreaseDecreaseInDeferredCompensationShareBasedArrangementsLiability",
                "unit": "usd",
                "value": 1738000
            },
            {
                "label": "Proceeds from related party debt financing",
                "concept": "ProceedsFromRelatedPartyDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from stock option exercises",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 17862000
            },
            {
                "label": "Net change in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -209638000
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": -2576000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": 3480000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": 3500000.0
            },
            {
                "label": "Interest payable (related party)",
                "concept": "myov:IncreaseDecreaseInInterestPayableRelatedPartyNetCurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Foreign currency transaction gain",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Foreign currency transaction gain",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 1062000
            },
            {
                "label": "Non-cash interest expense",
                "concept": "myov:InterestExpenseNoncash",
                "unit": "usd",
                "value": 1818000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -60308000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 118837000
            },
            {
                "label": "Amount due from related party",
                "concept": "IncreaseDecreaseInDueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 550000
            },
            {
                "label": "Cost share advance from Pfizer",
                "concept": "myov:IncreaseDecreaseInCollaborativeArrangementLiability",
                "unit": "usd",
                "value": -68654000
            },
            {
                "label": "Amounts due to related parties",
                "concept": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": -152000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 723000
            },
            {
                "label": "Share-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 30324000
            }
        ],
        "ic": [
            {
                "label": "Net loss per common share - basic (in USD per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -1.59
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -135408000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 82886000
            },
            {
                "label": "Net loss per common share - diluted (in USD per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": ""
            },
            {
                "label": "Loss before income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -145638000
            },
            {
                "label": "Income tax expense (benefit)",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 1058000
            },
            {
                "label": "Foreign exchange gain",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Foreign exchange gain",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Pfizer collaboration revenue",
                "concept": "RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
                "unit": "usd",
                "value": 79853000
            },
            {
                "label": "Pfizer collaboration revenue",
                "concept": "RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
                "unit": "usd",
                "value": 79853000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 192118000
            },
            {
                "label": "Total revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 173405000
            },
            {
                "label": "Total revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 173405000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 248000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Total operating costs and expenses",
                "concept": "myov:CostOfGoodsAndServicesSoldAndOperatingExpenses",
                "unit": "usd",
                "value": 308813000
            },
            {
                "label": "Weighted average common shares outstanding - basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 92514657
            },
            {
                "label": "Collaboration expense to Pfizer",
                "concept": "myov:CollaborationExpense",
                "unit": "usd",
                "value": 25912000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 10478000
            },
            {
                "label": "Weighted average common shares outstanding - diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146696000
            },
            {
                "label": "Total other comprehensive loss",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": "N/A"
            }
        ]
    }
}